UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                   AMENDMENT
                                       TO
                                   FORM 10-KSB
                 [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934
                  For the Fiscal Year Ended: 29 February, 2004
 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
                                     OF 1934
              For the transition period from _________ to _________
                          COMMISSION FILE NO. 333-86706
                           CROWN MEDICAL SYSTEMS, INC.
              Exact Name of Registrant as Specified in its Charter)
<TABLE>
            NEVADA                           7374                     98-0375957
            ------                           -----                    ----------
<S>                               <C>                             <C>
(State or Other Jurisdiction of  (Primary Standard Industrial        (IRS Employer
       Incorporation)              Classification Code Number)      Identification. No.)

</TABLE>
                  6006 N. MESA, SUITE 709, EL PASO, TEXAS 79912
               (Address of Principal Executive Offices) (Zip Code)

         Issuer's telephone number, including area code: (915) 845-1787

    Securities registered pursuant to Section 12(b) of the Exchange Act: None

  Securities registered pursuant to Section 12(g) of the Act: Common Stock, par
                             value $0.001 per share

Check whether the Issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
Yes _X_ No _____

Check if there is no disclosure of delinquent filers in response to Item 405 of
Regulation S-B is not contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy
information statements incorporated by reference in Part III of this Form 10-KSB
or any amendment to this Form 10-KSB.
Yes _X_ No _____

State issuer's revenues for its most recent fiscal year: Nil

State the aggregate market value of the voting and
non-voting common equity held by non-affiliates computed by reference to the
price at which the common equity was sold, or the average bid and asked price of
such common equity, as of a specified date within the past 60 days. (See
definition of affiliate in Rule 12b-2 of the Exchange Act.)

$14,112,000 as at June 9, 2004 based on the last sale price of our shares

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date.

20,451,835

                                        1
--------------------------------------------------------------------------------

This amendment is filed to add the Statement of Operations.



                           CROWN MEDICAL SYSTEMS, INC.

                      (Formerly Link Media Publishing Ltd.)

                          (a development stage company)

                      CONSOLIDATED STATEMENTS OF OPERATIONS

<TABLE>
                                                                                                         January 29,
                                                                     Year ended         Year ended          2002
                                                                 February 29, 2004     February 28,    (Inception) to
                                                                                           2003         February 29,
                                                                                                            2004
                                                                 ------------------- ----------------- ----------------
<S>                                                              <C>                 <C>               <C>
General and Administrative Expenses
    Consulting fees                                                    $1,000              $850            $5,050
    Office and general                                                 18,697             4,146            22,855
    Professional fees                                                  29,790             4,565            37,205
                                                                 ------------------- ----------------- ----------------
Loss from Continuing Operations                                       (49,487)           (9,561)          (65,110)
                                                                 ------------------- ----------------- ----------------

Discontinued Operations (Note 6)
    Loss from discontinued operations                                 (2,011)            (73,204)         (75,215)
    Gain on sale of discontinued operations                            2,495                -               2,495
                                                                 ------------------- ----------------- ----------------
Income (Loss) from Discontinued Operations                              484              (73,204)         (72,720)
                                                                 ------------------- ----------------- ----------------

Net Loss for the Year                                                $(49,003)          $(82,765)        $(137,830)
                                                                 =================== ================= ================

Basic Loss Per Share:
    From Continuing Operations                                        $(0.00)             $(0.00
    From Discontinued Operations                                       (0.00)             (0.00)
                                                                 ------------------- ----------------- ----------------

Basic Net Loss Per Share                                              $(0.00)            $(0.00)
                                                                 =================== ================= ================

Weighted Average Common Shares Outstanding                           31,838,447         31,832,506
                                                                 =================== ================= ================

</TABLE>

         The accompanying notes are an integral part of these consolidated
financial statements.




Exhibits

99.1 Certification of Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
99.2 Certification of Chief Financial Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of Section 13 and 15 (d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

Crown Medical Systems, Inc (formerly Link Media Publishing Ltd.)

By /s/William L. Sklar
----------------------------------
         William L Sklar
         President, CEO & Director
         Date: August 19, 2004

In accordance with the Securities Exchange Act, this report has been signed
below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.

By /s/William L. Sklar
----------------------------------
         William L Sklar
         President, CEO & Director
         Date: August 19, 2004

By /s/ G. Paul Marshall
----------------------------------
         Secretary, Treasurer and Director
         Date: August 19, 2004


By /s/ Darlene Cox
----------------------------------
         Darlene Cox
         Director
         Date: August 19, 2004


By /s/ Brian Knight
----------------------------------
         Brian Knight
         Director
         Date: August 19, 2004


By /s/ James Sterling
-----------------------------------
         James Sterling
         Director
         Date: August 19, 2004



Exhibit 99.1 CERTIFICATION

I, William L Sklar, President and Chief Executive Officer of Crown Medical
Systems, Inc. certify that:

1.      I have  reviewed  this  annual  report  on Form  10-KSB of Crown
Medical  Systems,  Inc.  (formerly  Link  Media Publishing Ltd.;)

2. Based on my knowledge, this annual report does not contain any untrue
statement of material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

        a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

         b)       evaluated the effectiveness of the registrant's  disclosure
controls and procedures as of a date within 90 days prior to the filing date of
this annual report (the "Evaluation Date"); and

         c)       presented in this quarterly  report our  conclusions  about
the  effectiveness  of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
the registrant's board of directors (or persons performing the equivalent
function):

         a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

         b)       any fraud,  whether or not  material,  that  involves
management  or other  employees who have a
significant role in the registrant's internal controls; and

6. The registrant's other certifying officer and I have indicated in this annual
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.


Date: August 19, 2004           /s/ William L Sklar
                                ----------------------------


     Exhibit 99.2 CERTIFICATION

I, G Paul Marshall,  Secretary,  Treasurer,  Chief  Financial  Officer and
Director of Crown Medical  Systems,  Inc
(formerly Link Media Publishing Ltd.), certify that:

1. I have reviewed this annual report on Form 10-KSB of Crown Medical Systems,
Inc.

2. Based on my knowledge, this annual report does not contain any untrue
statement of material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

         a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

         b)       evaluated the effectiveness of the registrant's  disclosure
controls and procedures as of a date
within 90 days prior to the filing date of this annual report (the "Evaluation
Date"); and

         c)       presented in this quarterly  report our  conclusions  about
the  effectiveness  of the disclosure
controls and procedures based on our evaluation as of the Evaluation Date;

5. The registrant's other certifying officer and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
the registrant's board of directors (or persons performing the equivalent
function):

         a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

         b)       any fraud,  whether or not  material,  that  involves
management  or other  employees who have a
significant role in the registrant's internal controls; and

6. The registrant's other certifying officer and I have indicated in this annual
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Date: August 19, 2004        /s/ G. Paul Marshall
                             -----------------------------